News on KaloBios Pharmaceuticals%2C Inc. from BioPortfolio.com http://www.BioPortfolio.com Consolidated KaloBios Pharmaceuticals%2C Inc. news from BioPortfolio.com Wed, 10 Feb 2010 13:32:41 GMT en KaloBios Pharmaceuticals, Inc.-Company Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028440&HITNO=0&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028440&THISHREF=http://c.moreover.com/click/here.pl%3fz2532722445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028440&HITNO=0&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028440&THISHREF=http://c.moreover.com/click/here.pl%3fz2532722445%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Sanofi-Aventis expands consumer health focus in Chinahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993440&HITNO=1&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993440&THISHREF=http://c.moreover.com/click/here.pl%3fz2514599953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3993440&HITNO=1&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3993440&THISHREF=http://c.moreover.com/click/here.pl%3fz2514599953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmafocus: More Financings as JPM Rolls on: BIND Gets $11M Series Chttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905256&HITNO=2&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905256&THISHREF=http://c.moreover.com/click/here.pl%3fz2466117924%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3905256&HITNO=2&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3905256&THISHREF=http://c.moreover.com/click/here.pl%3fz2466117924%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Sanofi Pasteur Partners with KaloBios on Novel Biologic for the Prevention and Treatment of Pseudomonas aerugihttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906527&HITNO=3&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906527&THISHREF=http://c.moreover.com/click/here.pl%3fz2466952623%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3906527&HITNO=3&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3906527&THISHREF=http://c.moreover.com/click/here.pl%3fz2466952623%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBionity.com: Sanofi Pasteur Partners with KaloBios on Novel Biologic for P. aeruginosa Infectionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907904&HITNO=4&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907904&THISHREF=http://c.moreover.com/click/here.pl%3fz2467616946%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3907904&HITNO=4&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3907904&THISHREF=http://c.moreover.com/click/here.pl%3fz2467616946%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioPharm International: KaloBios Obtains $35M Up Front from Sanofi Pasteur for Clinical Antibody Candidate againsthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904680&HITNO=5&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904680&THISHREF=http://c.moreover.com/click/here.pl%3fz2465800918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3904680&HITNO=5&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3904680&THISHREF=http://c.moreover.com/click/here.pl%3fz2465800918%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: KaloBios, Sanofi strike potential $290M dealhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3899192&HITNO=6&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3899192&THISHREF=http://c.moreover.com/click/here.pl%3fz2463220024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3899192&HITNO=6&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3899192&THISHREF=http://c.moreover.com/click/here.pl%3fz2463220024%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiz Journals: Sanofi Pasteur Partners with KaloBios on Novel Biologic for the Prevention and Treatment of Pseudomonas aeruginosa Infectionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3900229&HITNO=7&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3900229&THISHREF=http://c.moreover.com/click/here.pl%3fz2463768292%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3900229&HITNO=7&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3900229&THISHREF=http://c.moreover.com/click/here.pl%3fz2463768292%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMDLinx: Sanofi Pasteur, KaloBios Partner For Treatment of Pa Infectionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897892&HITNO=8&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897892&THISHREF=http://c.moreover.com/click/here.pl%3fz2462499921%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897892&HITNO=8&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897892&THISHREF=http://c.moreover.com/click/here.pl%3fz2462499921%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInfoGrok: Sanofi Pasteur Partners with KaloBios on Novel Biologic for the Prevention and Treatment of ...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898383&HITNO=9&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898383&THISHREF=http://c.moreover.com/click/here.pl%3fz2462762511%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3898383&HITNO=9&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3898383&THISHREF=http://c.moreover.com/click/here.pl%3fz2462762511%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPipelineReview: KaloBios, Sanofi strike potential $290M dealhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890368&HITNO=10&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890368&THISHREF=http://c.moreover.com/click/here.pl%3fz2459179994%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890368&HITNO=10&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890368&THISHREF=http://c.moreover.com/click/here.pl%3fz2459179994%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Business Journal: Pseudomonas Antibody Lands KaloBios Potential $290M Dealhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3891634&HITNO=11&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3891634&THISHREF=http://c.moreover.com/click/here.pl%3fz2459807207%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3891634&HITNO=11&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3891634&THISHREF=http://c.moreover.com/click/here.pl%3fz2459807207%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioWorld: KaloBios Partners With Sanofi Pasteur On Novel Prevention And Treatment For Pseudomonas Aeruginosahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3892026&HITNO=12&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3892026&THISHREF=http://c.moreover.com/click/here.pl%3fz2460017109%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3892026&HITNO=12&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3892026&THISHREF=http://c.moreover.com/click/here.pl%3fz2460017109%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: KaloBios Pharmaceuticals and Sanofi-Aventis form partnershiphttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894812&HITNO=13&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894812&THISHREF=http://c.moreover.com/click/here.pl%3fz2461133076%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894812&HITNO=13&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894812&THISHREF=http://c.moreover.com/click/here.pl%3fz2461133076%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Sanofi Pasteur, KaloBios will develop drug for bacterial infectionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894513&HITNO=14&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894513&THISHREF=http://c.moreover.com/click/here.pl%3fz2461005150%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3894513&HITNO=14&MSIZE=53&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=KaloBios%20Pharmaceuticals,%20Inc.&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3894513&THISHREF=http://c.moreover.com/click/here.pl%3fz2461005150%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: